Tracon Pharmaceuticals, Inc. (TCON)
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
Address
4350 LA JOLLA VILLAGE DRIVE
San Diego, CA 92122
Founded
2004
Number of Employees
17
Website
http://www.traconpharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)